Skip to main content
. 2016 Mar 10;4:e1791. doi: 10.7717/peerj.1791

Table 3. Literature evidence for the association between aspirin and the new targets.

Gene name Protein name Evidence Reference
MAPK12 Mitogen-activated protein kinase 12 MAPK12 gene polymorphism affect the efficacy of aspirin for prevention of rectal cancer; Treatment of the cell line SW480 with 1 mM aspirin for 48 h caused a significant down-regulation of MAPK12 expression. Dibra et al., 2010; Slattery, Lundgreen & Wolff (2012)
ITGAL Integrin alpha-L ITGAL gene is hypomethylated and associated with aspirin hypersensitivity in asthma. Cheong et al. (2011)
MMP12 Macrophage metalloelastase Aspirin inhibits LPS-induced MMP12 gene expression in human bronchial epithelial cells. Jiang et al. (2015)
TNFAIP6 Tumor necrosis factor-inducible protein 6 TNFAIP6 gene expression was up-regulated 2.33 fold by aspirin treatment in human peripheral blood mononuclear cells. Choi et al. (2005)
HLA-A MHC class I antigen HLA-DQw2 allele is involved in the pathogenesis of aspirin-sensitive asthma. Mullarkey et al. (1986)
RAC1 Ras-related C3 botulinum toxin substrate 1 RAC1 gene is highly induced in the HT29 colon cancer cell by aspirin. This study pointed towards a role for RAC1 in the action of aspirin in colon cancer. Hardwick et al. (2004)
TNFSF14 Tumor necrosis factor ligand superfamily member 14 Aspirin significantly reduced plasma levels of LIGHT in 12 healthy controls when given for 7 days (160 mg once a day). Otterdal et al. (2006)